Tech Company Financing Transactions

Karuna Therapeutics Funding Round

Karuna Therapeutics closed a $68 million Series B funding round on 3/19/2019. Investors included Arch Venture Partners, Alexandria Venture Investments and Eventide Asset Management.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
Proceeds from the financing will be used to advance the development of KarXT into several new indications, including geriatric psychosis and pain, progress new formulations of KarXT, expand the pipeline, and continue to build company infrastructure.

Company Information

Company Status
Mailing Address
33 Arch St. 3110
Boston, MA 02110
Email Address
Karuna Therapeutics (Nasdaq: KRTX) is a clinical-stage company targeting muscarinic cholinergic receptors for the treatment of psychosis and cognitive impairment across central nervous system (CNS) disorders.
Karuna Therapeutics LinkedIn Company Profile
Social Media
Karuna Therapeutics Company Twitter Account
Company News
Karuna Therapeutics News
Karuna Therapeutics on Facebook
Karuna Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Steven Paul
  Steven Paul LinkedIn Profile  Steven Paul Twitter Account  Steven Paul News  Steven Paul on Facebook
Chief Financial Officer
Troy Ignelzi
  Troy Ignelzi LinkedIn Profile  Troy Ignelzi Twitter Account  Troy Ignelzi News  Troy Ignelzi on Facebook
Chief Medical Officer
Stephen Brannan
  Stephen Brannan LinkedIn Profile  Stephen Brannan Twitter Account  Stephen Brannan News  Stephen Brannan on Facebook
Chief Operating Officer
Andrew Miller
  Andrew Miller LinkedIn Profile  Andrew Miller Twitter Account  Andrew Miller News  Andrew Miller on Facebook
Vice President
Giorgio Attardo
  Giorgio Attardo LinkedIn Profile  Giorgio Attardo Twitter Account  Giorgio Attardo News  Giorgio Attardo on Facebook
VP - Finance
Jason Brown
  Jason Brown LinkedIn Profile  Jason Brown Twitter Account  Jason Brown News  Jason Brown on Facebook
VP - R & D
Christian Felder
  Christian Felder LinkedIn Profile  Christian Felder Twitter Account  Christian Felder News  Christian Felder on Facebook



Browse more venture capital transactions:

Prev: 3/16/2019: Zeus venture capital transaction
Next: 3/19/2019: Tibber venture capital transaction


Share this article


About Our Venture Capital Transactions Database

We do our best to report on tech company VC transactions. All VC database entries reported here are derived from publicly available VC deal announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary